 | Up a level |
Milek, David; Echternacht, Scott R; LaGuardia, Jonnby; LaBarge, Dalton; Turpin, Loel; Grobbelaar, Adriaan; Leckenby, Jonathan I (2023). Evaluation of peripheral nerve regeneration in Murphy Roths Large mouse strain following transection injury. Regenerative medicine, 18(1), pp. 37-53. Future Medicine 10.2217/rme-2022-0098
Nemecek, Zdenek; Sturm, Constanze; Rauen, Anna C; Reisig, Florian; Streitberger, Konrad; Harnik, Michael A (2023). Ultrasound-controlled cryoneurolysis for peripheral mononeuropathies: a retrospective cohort study. Pain management, 13(6), pp. 363-372. Future Medicine 10.2217/pmt-2023-0053
Chan, Andrew; Silván, Carlos Vila (2022). Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap. Neurodegenerative disease management, 12(3), pp. 141-154. Future Medicine 10.2217/nmt-2022-0002
Torkildsen, Øivind; Linker, Ralf A; Sesmero, Jose Mm; Fantaccini, Simone; Sanchez-de, la Rosa Rainel; Seze, Jerome de; Duddy, Martin; Chan, Andrew (2021). Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders. Neurodegenerative disease management, 11(1), pp. 9-19. Future Medicine 10.2217/nmt-2020-0054
Andereggen, Lukas; Widmer, Hans Rudolf; Di Santo, Stefano; Andres, Robert Hans (2020). Functional muscle strength recovery from nail gun injury to the primary motor cortex. Regenerative medicine, 15(5), pp. 1603-1609. Future Medicine 10.2217/rme-2019-0146
Eggimann, Philippe; Que, Yok-Ai; Rebeaud, Fabien (2019). Measurement of pancreatic stone protein in the identification and management of sepsis. Biomarkers in medicine, 13(2), pp. 135-145. Future Medicine 10.2217/bmm-2018-0194
Chortarea, Savvina; Fytianos, Kleanthis; Rodriguez-Lorenzo, Laura; Petri-Fink, Alke; Rothen-Rutishauser, Barbara (2018). Distribution of polymer-coated gold nanoparticles in a 3D lung model and indication of apoptosis after repeated exposure. Nanomedicine, 13(10), pp. 1169-1185. Future Medicine 10.2217/nnm-2017-0358
Hamzic, Seid; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy? Pharmacogenomics, 19(8), pp. 689-692. Future Medicine 10.2217/pgs-2018-0040
Chan, Andrew; Cutter, Gary; Fox, Robert J; Xiao, James; Lewin, James B; Edwards, Michael R (2017). Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison. Journal of comparative effectiveness research, 6(4), pp. 313-323. Future Medicine 10.2217/cer-2016-0085
Di Spiezio Sardo, Attilio; Spinelli, Marialuigia; Zizolfi, Brunella; Nappi, Carmine (2016). Ambulatory management of heavy menstrual bleeding. Women's health, 12(1), pp. 35-43. Future Medicine 10.2217/whe.15.80
Wyss, Pradeep P; Lamichhane, Surya; Rauber, Martin; Thomann, Ralf; Krämer, Karl; Shastri, V Prasad (2016). Tripod USPIONs with high aspect ratio show enhanced T2 relaxation and cytocompatibility. Nanomedicine, 11(9), pp. 1017-1030. Future Medicine 10.2217/nnm.16.8
Fytianos, Kleanthis; Drasler, Barbara; Blank, Fabian; Von Garnier, Christophe; Seydoux, Emilie; Rodriguez-Lorenzo, Laura; Petri-Fink, Alke; Rothen-Rutishauser, Barbara (2016). Current in vitro approaches to assess nanoparticle interactions with lung cells. Nanomedicine, 11(18), pp. 2457-2469. Future Medicine 10.2217/nnm-2016-0199
Bochkov, Valery; Schoenenberger, Andreas; Oskolkova, Olga; Toth, Ursula; Stöckl, Johannes; Majdic, Otto; Daci, Armond; Resink, Thérèse J; Erne, Paul; Philippova, Maria (2016). Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids. Biomarkers in medicine, 10(8), pp. 797-810. Future Medicine 10.2217/bmm-2016-0096
Liechti, Fabian D; Grandgirard, Denis; Leib, Stephen (2015). Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies. Future microbiology, 10(7), pp. 1195-1213. Future Medicine 10.2217/fmb.15.43
Kummer, Dominic; Fröhlich, Tanja; Joerger, Markus; Aebi, Stefan; Sistonen, Johanna; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2015). Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. Pharmacogenomics, 16(12), pp. 1367-1377. Future Medicine 10.2217/pgs.15.81
Visscher, Henk; Rassekh, S Rod; Sandor, George S; Caron, Huib N; van Dalen, Elvira C; Kremer, Leontien C; van der Pal, Helena J; Rogers, Paul C; Rieder, Michael J; Carleton, Bruce C; Hayden, Michael R; Ross, Colin J; Amstutz, Ursula; Canadian Pharmacogenomics Network for Drug Safety consortium, CPNDS (2015). Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics, 16(10), pp. 1065-1076. Future Medicine 10.2217/pgs.15.61
Rothen-Rutishauser, Barbara; Kuhn, Dagmar; Ali, Zulqurnain; Gasser, Michael; Amin, Faheem; Parak, Wolfang J.; Vanhecke, Dimitri; Fink, Alke; Gehr, Peter; Brandenberger, Stefanie Christina (2014). Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine, 9(5), pp. 607-621. Future Medicine 10.2217/nnm.13.24
Vanhecke, Dimitri; Rodriguez-Lorenzo, Laura; Clift, Martin J D; Blank, Fabian; Petri-Fink, Alke; Rothen-Rutishauser, Barbara (2014). Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. Nanomedicine, 9(12), pp. 1885-1900. Future Medicine 10.2217/nnm.14.108
Beyoglu, Diren; Idle, Jeffrey (2014). A history and overview of phenotypic variability in CYP2D6 activity. In: Baumann, Pierre (ed.) CYP2D6: Genetics, Pharmacology and Clinical Relevance (pp. 8-27). London: Future Medicine 10.2217/FMEB2013.13.97
Sistonen, Johanna; Büchel, Barbara; Fröhlich, Tanja; Kummer, Dominic; Fontana, Stefano; Joerger, Markus; van Kuilenburg, André B P; Largiadèr, Carlo Rodolfo (2014). Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio. Pharmacogenomics, 15(13), pp. 1653-1666. Future Medicine 10.2217/pgs.14.126
Gustafsson, Finn; Gude, Einar; Sigurdardottir, Vilborg; Aukrust, Pål; Solbu, Dag; Goetze, Jens-Peter; Gullestad, Lars (2014). Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels. Biomarkers in medicine, 8(2), pp. 239-245. Future Medicine 10.2217/bmm.13.95
Fuhrmann, Gloria; Swart, Estienne; Nowacki, Mariusz; Lipps, Hans J. (2013). RNA-dependent genome processing during nuclear differentiation: the model systems of stichotrichous ciliates. Epigenomics, 5(2), pp. 229-236. Future Medicine 10.2217/epi.13.15
Kölzer, Viktor H.; Lugli, Alessandro (2013). T-cell infiltrates and tumor budding: promising prognostic factors in the tumor microenvironment of colorectal cancer. Colorectal Cancer, 2(3), pp. 173-176. Future Medicine 10.2217/CRC.13.26
Andres, RH; Andereggen, L; Mordasini, P; Ducray, Angélique; Ibatullin, R; Raabe, A; Barth, A; Widmer, HR (2012). Responses of the Dopaminergic and Endogenous Neurogenic Systems in a Rat Model of Intracerebral Hemorrhage. Regenerative medicine London: Future Medicine
Amstutz, Ursula; Froehlich, Tanja K; Largiadèr, Carlo R (2011). Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics, 12(9), pp. 1321-36. London: Future Medicine 10.2217/PGS.11.72
Becquemont, Ana; Amstutz, Ursula; Brauch, Hiltrud; Jacqz-Aigrain, Evelyne; Laurent-Puig, Pierre; A Molina, Miguel; Niemi, Mikko; Schwab, Matthias; A Somogyi, Andrew; Thervet, Eric; Maitland-van der Zee, Anke-Hilse; van Kuilenburg, André; van Schalk, Ron; Verstuyft, Céline; Wadelius, Mia; K Daly, Ann (2011). Practical recommendations for pharmacogenomics - based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics, 12(1), pp. 113-124. London: Future Medicine 10.2217/pgs.10.147
Stamer, Ulrike M; Zhang, Lan; Stüber, Frank (2010). Personalized therapy in pain management: where do we stand? Pharmacogenomics, 11(6), pp. 843-64. London: Future Medicine 10.2217/PGS.10.47
Schwerzmann, Markus; Meier, Bernhard (2010). Impact of percutaneous patent foramen ovale closure on migraine course. Interventional cardiology, 2(2), pp. 177-187. Future Medicine 10.2217/ica.10.6
Amstutz, U; Farese, S; Aebi, S; Largiadèr, CR (2009). Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: A haplotype assessment. Pharmacogenomics, 10(6), pp. 931-944. London: Future Medicine 10.2217/PGS.09.28
Rauch, Andri; Gaudieri, Silvana; Thio, Chloe; Bochud, Pierre-Yves (2009). Host genetic determinants of spontaneous hepatitis C clearance. Pharmacogenomics, 10(11), pp. 1819-37. London: Future Medicine 10.2217/PGS.09.121
Martin, Annalise; Nolan, David; Almeida, Coral-Ann; Rauch, Andri; Mallal, Simon (2006). Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again. Pharmacogenomics, 7(1), pp. 15-23. London: Future Medicine 10.2217/14622416.7.1.15
